Review of Postoperative Delirium in Geriatric Patients After Hip Fracture Treatment

Abstract

Introduction

Postoperative delirium (POD) is a serious complication occurring in 4–53.3% of geriatric patients undergoing surgeries for hip fracture. Incidence of hip fractures is projected to grow 11.9% from 258,000 in 2010 to 289,000 in 2030 based on 1990 to 2010 data. As prevalence of hip fractures is projected to increase, POD is also anticipated to increase.

Signficance

Postoperative delirium remains the most common complication of emergency hip fracture surgery leading to high morbidity and mortality rates despite significant research conducted regarding this topic. This study reviews literature from 1990 to 2021 regarding POD in geriatric hip fracture management.

Results

Potentially modifiable and non-modifiable risk factors for developing POD include, but are not limited to, male gender, older age, multiple comorbidities, specific comorbidities (dementia, cognitive impairment, diabetes, vision impairment, and abnormal blood pressure), low BMI, preoperative malnutrition, low albumin, low hematocrit, blunted preoperative cytokines, emergency surgery, time to admission and surgery, preoperative medical treatment, polypharmacy, delirium-inducing medications, fever, anesthesia time, and sedation depth and type. Although the pathophysiology remains unclear, the leading theories suggest neurotransmitter imbalance, inflammation, and electrolyte or metabolic derangements as the underlying cause of POD. POD is associated with increased length of hospital stay, cost, morbidity, and mortality. Prevention and early recognition are key factors in managing POD. Methods to reduce POD include utilizing interdisciplinary teams, educational programs for healthcare professionals, reducing narcotic use, avoiding delirium-inducing medications, and multimodal pain control.

Conclusion

While POD is a known complication after hip fracture surgery, further exploration in prevention is needed. Early identification of risk factors is imperative to prevent POD in geriatric patients. Early prevention will enhance delivery of health care both pre- and post-operatively leading to the best possible surgical outcome and better quality of life after hip fracture treatment.

Introduction

Per clinical definition, delirium is a rapid—though often waxing and waning—decline in neurocognitive function, presenting as altered consciousness or changes in attention that cannot be explained by a pre-existing neurocognitive disorder. ¹ Three types of delirium exist: hyperactive delirium, hypoactive delirium, and mixed delirium.^1,2 Restlessness, excitability, and agitation are descriptive of a hyperactive delirious state, whereas lethargy, inactivity, and disinterest are descriptive of a hypoactive delirious state. ³ Mixed delirium displays a combination of hyperactive and hypoactive delirium features. ⁴

While POD can be a complication of both elective and traumatic hip surgeries, it is far more prevalent in traumatic hip fracture patients. ⁵ This indicates a therapeutic need for deeper understanding of prevention, detection, and management of POD in the scope of non-elective surgeries. ⁵ Prevention and early recognition are key factors in managing POD. ^{6, 7}  Exact incidence of POD in hip fracture patients varies by study and population, ranging from 4 to 53.3%.^5,8-18 A recent research article analyzed patients with hip fracture aged 60 years and older identified in the 2016 and 2017 National Surgical Quality Improvement Program Procedure Targeted Databases. ¹⁹ Postoperative delirium was found to be a potentially preventable postoperative adverse outcome and was seen in 18.8% of 18,754 patients with hip fractures. ¹⁹ Interestingly, although women have a higher hip fracture incidence, ²⁰ men are more likely to be diagnosed with POD following hip fracture treatment.^9,12 Other risk factors for POD include indoor injury, ¹⁸ older age,^21-23 prior dementia diagnosis or cognitive impairment,^18,21 diabetes, ²³ multiple comorbidities, ²² American Society of Anesthesiologists classification >2 level,^13,23 vision impairment, ²² low BMI, ¹⁸ preoperative malnutrition, ²⁴ low albumin, ²¹ low hematocrit, ²¹ and blunted preoperative cytokine levels. ²⁵ Further studies identified risk factors for POD in the perioperative period including patients undergoing emergency surgery, ²² time to admission, ²² preoperative waiting time, ²¹ preoperative medical treatment, ²² the use of multiple prescription medications, ²¹ treatment with antibiotics, ²² anesthesia time, ²² use of midazolam, ² abnormally high or abnormally low blood pressure, ²⁶ fever, ¹⁸ and depth and type of sedation.^9,27

Frailty is recognized as a factor in surgical and geriatric outcomes^28-30 which is defined as a state of diminished physiologic capacity to respond to external stressors such as trauma and infections in vulnerable individuals. ³¹ It is important to note the association between physical frailty and cognitive function reported by cross-sectional studies.^32,33 Physical frailty may lead to cognitive decline and vice versa.^34-37 Thus, one might expect patients with either physical frailty or cognitive decline to be at risk for delirium. One study examined the relationship between physical frailty and cognitive decline in a single-center retrospective study of older patient who had undergone cardiac surgery. ³⁸ They found that the coexistence of physical frailty and mild cognitive impairment poses the greatest risk of delirium whereas either alone has no significant risk for the incidence of delirium. ³⁸ In addition, another study found the modified frailty index is an independent predictor of mortality for patients undergoing hemi-arthroplasty and total hip arthroplasty. ³⁹

Not only is POD the most common complication of surgical hip fracture treatment but it also significantly contributes to extended length of hospital stay, institutional discharge, and rate of 30-day readmission. ¹⁶ POD is a risk factor for multiple short-term and long-term complications, influencing physical recovery,^11,15 cognitive recovery,^15,40 and higher episode-of-care cost. ¹⁷ Studies support that incidence of POD may be a large contributor to the high 1-year mortality rate of traumatic hip fractures, reporting that 6-month^41,42 to 1-year ⁴³ mortality is significantly increased in hip fracture patients diagnosed with POD compared to patients not diagnosed with POD.^9,41-45

Hip fracture repair is commonly associated with postoperative complications including, but not limited to, postoperative delirium (POD), urinary tract infection/retention, dislocation of prosthesis, stroke, deep vein thrombosis, cardiac events, pneumonia, and wound infection. ¹⁰ A third of patients experience at least one postoperative complication, with 7.2% experiencing more than one. ¹⁰ Of the possible postoperative complications, the most common in traumatic hip fracture patients is POD. ¹⁰

With age comes progressive deterioration of bone mass,^46,47 consequently increasing risk for fracture. Though not the most common fracture site with age, hip fractures have become the most feared fracture site with age—riddled with serious preoperative, short-term postoperative, and long-term postoperative complications,^9,15,48,49 including a 12.7% 1-year mortality rate, according to a prospective cohort study. ⁵⁰ From 2014 to 2017, the incidence of hip fractures plateaued at approximately 1.77 per 1000-person years and 1.75 per 1000-person years, respectively, ⁵¹ but is projected to grow 11.9% from 258,000 in 2010 to 289,000 in 2030 based on 1990 to 2010 data. ⁵² There is a higher incidence of hip fractures in women (957.3 per 100,000 person years) than men (414.4 per 100,000 person years), ²⁰ likely a result of increased prevalence of osteoporosis in post-menopausal women, ⁴⁷ though incidence rates rise exponentially in both genders with age. ⁴⁶ The most common mechanism of hip fracture in the geriatric patients (>65) is an accidental lateral fall from standing, ⁵³ at average ages of 83 years in women and 84 years in men. ⁵⁴ Limited data are available on hip fracture trends based on ethnic or racial subgroups, and one study describes global hip fracture epidemiology separated by regions and reports increased hip fracture rates in industrialized countries compared to developing countries. ⁵⁵

Pathophysiology

There is extensive research that highlights the connection between postoperative hip fractures and delirium in geriatric patients. The exact pathogenesis and physiology of how this process occurs remains unclear, the leading theories suggest neurotransmitter imbalance, inflammation, and electrolyte or metabolic derangements as the underlying cause of POD ⁵⁶

Cortical regions of the brain have been implicated as the site of origin in the pathways leading up to a delirious state. ⁵⁷ Dysfunctions in the prefrontal cortex, subcortical structures, thalamus, basal ganglia, frontal temporoparietal cortex, fusiform cortex, and lingual gyri have all been found to have some part in causing the state of delirium. ⁵⁷ Most importantly, with the relevance to hip fractures, delirium has been noted to be influenced and conceived in a state of an inflammatory storm, chronic stress, and/or neurotransmitter chemical alterations. ⁵⁸ In addition, recent research has linked metabolic alterations (fatty acid and amino acid serum concentration changes) in association with postoperative delirium following hemi-arthroplasty in older patients. ⁵⁹

Hip fracture surgery is a known risk factor in itself for delirium. ⁶⁰ One potential theory to why surgery itself causes delirium ⁶⁰ is that pain and inflammation, compounded with stress and repair causes inflammatory chemicals to be systemically released throughout the body ⁵⁷ during the surgical procedure. The pathogenesis of delirium has mostly been attributed to neurotransmission, inflammation, and chronic stress. ⁵⁸ Cytokines are chemicals secreted by the cells during times of cellular damage and repair. Cytokines such as interleukins (IL), tumor necrosis factor alpha (TNF-α), and interferons (IFN) play an intricate role in the inflammatory process. ⁶¹ Likewise, increase levels of cytokines seem to have a connection in causing delirium. ⁶¹ Interleukin-1 (IL-1),^57,61 IL-2 (a T-cell activator), ⁵⁷ IL-6 (pro-pyrogenic molecules), ⁵⁷ and TNF-α^57,61 have all been suspected of causing delirium.

Cells undergoing a response to stress, inflammation, and tissue damage release cytokines which directly influence the hippocampus and amygdala to secrete neurotransmitters and activate the sympathetic nervous system. ⁵⁷ As such, the hypothalamic hormonal axis will secrete a large concentration of hormones that will affect the pituitary gland which will subsequently affect the adrenal glands as they [adrenal glands] will secrete adrenocortical hormone in order to minimize the level of stress that is endured by the inflammatory process. ⁶² A chronic state of high cortisol levels will contribute to vast neurotransmitter processes within the body possibly contributing to the effects of delirium. ⁵⁷

Evidence has also pointed to a lack of cholinergic activity in the brain as a contributory factor to the initiation of a delirium state. ⁵⁸ Abnormally high levels of dopamine have also been linked to delirium as they regulate the release of acetylcholine. ⁵⁷ Imbalances in other neurotransmitters such as γ-aminobutyric acid, glutamate, and norepinephrine have also been linked to inducing delirium. ⁵⁷

Alterations in variables related to metabolism have been associated to causing delirium in postoperative hemi-arthroplasty in geriatric patients. ⁵⁹ Recent studies have been conducted to measure important metabolic elements pre- and post-surgery in both POD and non-postoperative delirium (NPOD) patients to detect differences among both groups. Data have indicated that deficiencies in Omega-3 and Omega-6 fatty acids exist in POD patients when compared to NPOD patients. ⁵⁹ Branched-chain amino acid (BCAA)/aromatic amino acid ratio was also measured to being lower in the POD group than in the NPOD group post-surgery. ⁵⁹ This recent discovery has opened the discussion for other possible mechanisms of postoperative hip surgery delirium in the geriatric population.

Metabolites such as arachidonic acid, hexadecatrienoic acid, and eicosapentaenoic acid (EPA) among others were decreased before and significantly decreased after surgery in POD patients. ⁵⁹ These and other fatty acids are important for the development of myelination by oligodendrocytes. ⁵⁹ Thus, a lack of fatty acids causes neurodegenerative effects and is associated with delirium post-hip fracture. ⁵⁹

Even though we do not fully understand the process of delirium post-hip fractures in geriatric patients, we understand some basic pathways that have been investigated and later contributed to the state of delirium. We can infer from such pathways the general understanding of how delirium is caused. Overall, the pathogenesis of POD has vast etiologies. The inflammatory response involving cytokines, cortisol, neurotransmitters, and metabolites are all a contributory factor in causing delirium in postoperative surgeries involving complex hip fractures.

Patient Outcomes

Geriatric patients who experience traumatic hip fracture are prone to more postoperative complications compared to patients receiving elective surgery. ⁶³ POD is the most common diagnosed postoperative complication in hip fracture patients, exhibiting a unique presentation of physical and cognitive short-term and long-term outcomes per patient. ¹⁰

Physical Outcomes

Short-term physical outcome trends noted in hip fracture patients diagnosed with POD include worse surgical outcomes, ⁴⁸ increased difficulty for independent living,^9,48 prolonged length of hospital stay,^9,48,49 elevated incidence of discharge to a care facility rather than to prior dwelling,^14,49 and an increased 30-day readmission rate. ⁴⁹

Though a diagnosis of POD does not guarantee the onset of serious long-term physical deficits, negative functional outcomes are common and serious, especially compared to patients never diagnosed with POD following hip fracture repair.^9,14,15 On the milder side of the spectrum, hip fracture patients with POD were less likely to both recover their pre-fracture level of ambulation ⁹ and reap optimal rehab results in the months following surgery. ⁴⁵ The more serious long-term physical outcomes associated with POD in hip fracture patients included higher likelihood of becoming wheelchair bound or bedridden, ¹⁴ higher occurrence of severe dependency for basic activities of daily life,^9,15 and increased nursing home placement post-surgery. ⁸

The effect of POD on hip fracture patient mortality is of great concern and interest. Considering the short term, the presence or absence of POD did not affect in-hospital mortality. ⁹ Looking toward the long term, however, there is a general consensus that mortality by 6-month follow-up significantly increases in hip fracture patients diagnosed with POD compared to hip fracture patients without POD,^14,41,42 one study reporting a 28.1% mortality in POD hip replacement patients vs a 13.4% NPOD mortality by 6 months post-procedure. ⁴² Further trends suggest that there is an increased risk of 6-month mortality for each additional day a patient experiences POD. ⁴² Persistent delirium, continuing for months after hip fracture repair, is further implicated in a significantly increased 1-year mortality rate, one study concluding that persistent POD rendered patients 2.9 times more likely to die by 1-year post-procedure compared to patients whose delirium quickly resolved. ⁴³

Cognitive Outcomes

Postoperative delirium itself is a cognitive outcome of traumatic hip fracture, but POD is also associated with a variety of other short-term and long-term cognitive outcomes. The short-term effects of POD are associated with patient-specific presentations of changes in mental status and psychomotor activity—which can be classified as hyperactive delirium, hypoactive delirium, or mixed delirium.^1,2 All subtypes of delirium have been recorded in patients with POD following treatment for a hip fracture, but studies do not agree on which subtype is more common in this population.^2,64 In addition to changes in attention and awareness, patients can present with transient bouts of hallucinations, ¹⁴ anxiety, ¹⁴ depression, ¹⁴ delusions, ¹⁴ emotionalism, ¹⁴ and/or general cognitive dysfunction. ⁶⁵ All of these mental status changes can impede trajectory of physical recovery from surgery.

Not only did hip fracture patients with POD acutely experience depressed cognitive function compared to hip fracture patients without POD, but a continuation of significantly blunted cognitive function was found at 38 months post-surgery in POD vs NPOD hip fracture patients. ¹⁵ Another study found this same trend in patients at 1-month follow-up and 1-year follow-up. ⁶⁵ Patients without a history of dementia who experienced POD exhibited an increased risk for future dementia diagnosis compared to non-POD patients, with permanent deficits in memory, spatial orientation, and abstract thinking. ⁴⁰ Finally, the incidence of POD in patients already diagnosed with Alzheimer disease may cause an accelerated cognitive decline. ⁶⁶

Economic Impact

Delirium itself has a high economic impact on healthcare and government spending. POD has been associated with increased time of hospital stay. ¹⁷ A study performed at Toronto Western Hospital found that POD in hip fracture patients was associated with an approximate 7.4 day longer stay and an $8286 (Canadian dollars) increase in healthcare fees during this time. ¹⁷ In another study conducted at the University of California, Davis, Medical Center, researchers discovered that developing POD or other in-hospital complications and length of time to surgery were predictive of an increased LOS. ⁶⁷

Some organizations within certain nations have begun to implement programs and initiatives that encourage incentives for developing assessment protocols for delirium. Hospital Elder Life Program (HELP) is currently practiced in the United States, Australia, and other nations. ⁶⁸ Components of the HELP program include implementing targeted interventions by a skilled interdisciplinary team to address issues that contribute to cognitive and functional decline during hospitalization. ⁶⁹ Teams consist of geriatric nurse specialists, specially trained Elder Life Specialists, and trained volunteers. ⁶⁹ Issues addressed include cognitive orientation and stimulation activities, therapeutic activities, sleep enhancement strategies, exercise and mobilization, hearing and vision aids, feeding assistance and preventing dehydration, pastoral care, family support and education, and individualized discharge planning. ⁶⁹ This program investigates and assesses both the costs and benefits of implementing such protocols. ⁷⁰ In one study, a 40-bed unit saved $626,261 in over 6 months for 704 patients after utilizing the HELP protocol. ⁷⁰ In one hospital utilizing the HELP protocol, over 7000 patients in 6 hospital units were served by the program which resulted in approximately $7.3 million of total savings in 2008. ⁶⁸

With the growing costs of health care and the complexities of medicine, physicians need to implement protocols to reduce delirium cases within patients. Delirium, as mentioned above, has a high burden and a great toll on the economy. Cases of delirium are only compounded into more severe cases should the patient be a postoperative hip fracture patient. The high costs of wrap-around treatment in addition to the burden on both the hospitals, long-term care facilities, and caregivers makes the creation of such protocols necessary to better the health outcomes of the patient.

Screening and Diagnosing

There are various screening tools used to assess delirium with varying sensitivities and specificities (Table 1). The Confusion Assessment Method (CAM) ⁷¹ (Appendix Tables A1 and A2) is the most commonly used screening tool to assess delirium. ⁷² However, a systematic review of delirium screening tools found wide ranges in sensitivity (46–100%) and specificity (63–100%) for CAM likely resulting from variations in user training and comfortability with the method. ⁷² The Memorial Delirium Assessment Scale had a low sensitivity (64.1%) and a high specificity (100%). ⁷² In addition, the Delirium Rating Scale (DRS)/Delirium Rating Scale-Revised-98 (DRS-R-98) had a high sensitivity (91-100%) and a relatively lower specificity (84-92%). ⁷² It is important to note that each of these screening tools is most useful after specific training for optimum performance. ⁷² For instance, the DRS/DRS-R-98 requires psychiatric training. ⁷²

Table 1.

Screening and Diagnostic Tools to Diagnose POD and Their Respective Sensitivities and Specificities.

Screening method	Sensitivity	Specificity
Confusion Assessment Method	46–100% 72	63–100% 72
DRS/DRS-R-98	91–100% 72	84–92% 72
Memorial Delirium Assessment Scale	64.1% 72	100% 72
Diagnostic method	Sensitivity	Specificity
DSM-V (strict criteria compared to DSM-IV)	30% (95% CI 26 to 35) 73	99% (95% CI 97 to 99) 73
DSM-V (relaxed criteria compared to DSM-IV)	89% (95% CI 86 to 92) 73	96% (95% CI 93 to 98) 73

There is no standardized, validated tool to diagnose POD, specifically. Diagnosis requires a multi-factorial approach by trained medical professionals, often starting with a perceived cognitive shift by family or a provider. The American Geriatric Society Best Practice statement recommends using Diagnostic and Statistical Manual of Mental Disorders (DSM), ICD-10, or Confusion Assessment Method to diagnose delirium. ⁷⁴ In addition, they also recommend healthcare personnel be trained to recognize all forms of delirium ⁷⁴ considering hypoactive delirium may have worse outcomes due to under recognition, diagnosis, and treatment. ⁷⁵ One study assessed the concordance between DSM-IV and DSM-V criteria to diagnose delirium ⁷³ (Table 1). This study found DSM-V using strict criteria compared to the DSM-IV had a low sensitivity, 30% (95% CI 26 to 35), but a high specificity, 99% (95% CI 97 to 99). ⁷³ Alternatively, the DSM-V using relaxed criteria compared to the DSM-IV showed a higher sensitivity, 89% (95% CI 86 to 92), and a comparable specificity, 96% (95% CI 93 to 98). ⁷³

Prevention and Treatment

Clinical management of delirium is broadly categorized into non-pharmacologic and pharmacologic approaches. Both approaches aim to address the underlying cause of the delirium in prevention and treatment.

Non-Pharmacologic

In 2015, the American Geriatrics Society published a postoperative delirium in older adults best practice statement which highlights 3 key non-pharmacologic components to prevent and treat postoperative delirium: (1) implementing formal education programs for healthcare systems and hospitals, (2) implementing multicomponent non-pharmacologic interventions to prevent postoperative delirium in high-risk patients which are overseen by an interdisciplinary team, and (3) utilize interdisciplinary teams to deliver multicomponent interventions once a patient has been diagnosed with postoperative delirium. ⁷⁴ In addition, it states that there is insufficient evidence regarding the use of delirium units for treatment. ⁷⁴ Multicomponent interventions (Table 2) specifically targeted minimizing delirium risk such as minimizing time to surgery, ⁷⁶ sensory enhancements (visual aids, hearing aids, etc.),^70,77-80 mobility enhancement,^77,79,81,82 cognitive stimulation,^70,77,79,82 nutritional and fluid repletion enhancement,^70,77,79,81 sleep enhancement,^70,77,79,81 and environmental familiarity. ⁸⁰

Table 2.

Non-Pharmacologic and Pharmacologic Approaches to Clinically Managing Post-Operative Delirium.

Non-pharmacologic	Pharmacologic
Education on POD	Regional analgesia and multimodal pain control76,81
• Health care team78,81,83
• Patient family members 80
Minimizing the time to surgery 76	Reduce narcotic use 84
Utilizing interdisciplinary approach	Medication review
• Multicomponent non-pharmacologic intervention programs70,81	• Reduction of polypharmacy or delirium exacerbating medications76,78
Sensory enhancement	Avoid the following drugs or drug classes
• Ensuring glasses77-80	• Drugs with anticholinergic properties 85
	• Corticosteroids 86
• Visual aids and adaptive equipment70,77-80	• Meperidine 87
• Hearing aids and listening amplifiers70,77-80	• Benzodiazepines 87
Mobility enhancement	Starting >3 new medications increases the risk of delirium88,89
• Early mobilization79,81,82
• Ambulating patients daily77,78,81
• Minimizing immobility equipment (such as restraints or urinary catheter)77,78,81
Cognitive stimulation70,77,79,82	Supplemental oxygen76,81
Nutritional and fluid repletion enhancement76,79,81,82
Sleep enhancement70,77,79,81
• At bedtime, warm drink (milk or herbal tea), relaxation tapes or music, and back massage. Unit-wide noise-reduction strategies (e.g., silent pill crushers, vibrating beepers, and quiet hallways) and schedule adjustments to allow sleep (e.g., rescheduling of medications and procedures).77,79
Environmental familiarity
• Placing familiar objects to the patient in the rooms 80
• Extending visiting hours 80
• Reorientation by family members 80

Non-pharmacologic interventions (Table 2) for prevention of delirium have shown to reduce the incidence by 27–100%.^76,78,80-83 Despite the decrease of incidence of delirium after the implementation of multicomponent interventions, one study found that mortality, length of stay, functional status, and disposition remained similar in both the intervention and non-intervention groups. ⁸³ Other studies identified similar outcomes for those in the intervention group who experienced delirium finding no significant difference in severity, length, and recurrence of episodes of delirium.^77,78 However, multicomponent interventions can reduce complications (Lundstrom 2007), hospital length of stay, ⁸¹ days with delirium,^77,81 total number of episodes, ⁷⁷ the rate of functional decline,^78,82 nutritional status decline, ⁸² and improve other quality interventions. ⁷⁸

Pharmacologic

The 2015 American Geriatrics Society postoperative delirium in older adults best practice statement also highlights 3 key pharmacologic components to prevent and treat postoperative delirium: (1) utilizing regional anesthesia, (2) pain control should be optimized with nonopioid drugs, and (3) cholinesterase inhibitors should not be newly prescribed to a patient to prevent or treat delirium. ⁷⁴ The statement also addresses that there is insufficient evidence regarding prophylactic use of antipsychotics. ⁷⁴ Pharmacologic interventions (Table 2) mainly center around the reduction^{76,78,84,88,89} or avoidance ⁸⁵ of using medications to prevent or treat delirium. Certain medications or a combination of multiple medications (Table 2) have been found to increase the incidence of delirium in geriatric patients. Specifically, drugs with anticholinergic properties, ⁸⁵ corticosteroids, ⁸⁶ meperidine, ⁸⁷ and benzodiazepines ⁸⁷ have been shown to be significantly associated with delirium. Other pharmacologic interventions (Table 2) include providing regional analgesia, multimodal pain control, and supplemental oxygen.^76,81

Conclusion

Postoperative delirium remains the most common complication of emergency hip fracture surgery despite significant research conducted regarding this topic. Additionally, patients experiencing POD after hip fracture treatment have a high morbidity and mortality rate. This study found that early prevention, recognition, and treatment of POD are important for obtaining the best surgical outcomes for geriatric patients after hip fracture management. Future investigations should focus on application of multimodal interventions in both the prevention and treatment of POD in hip fracture patients as they have been shown to decrease the incidence of delirium.

Table A1. The Confusion Assessment Method Instrument ⁷¹

Table A1. The Confusion Assessment Method Instrument.

⁷¹

Acute onset
Is there evidence of an acute change in mental status from the patient’s baseline?
Inattention*
A. Did the patient have difficulty focusing attention, for example, being easily distractable, or having difficulty keeping track of what was being said?
Not present at any time during interview.
Present at some time during interview, but in mild form.
Present at some time during interview, in marked form.
Uncertain.
B. (If present or abnormal) Did this behavior fluctuate during the interview, that is, tend to come and go or increase and decrease in severity?
Yes.
No.
Uncertain.
Not applicable.
C. (If present or abnormal) Please describe this behavior:
Disorganized thinking
Was the patient’s thinking disorganized or incoherent, such as rambling or irrelevant conversation, unclear or illogical flow of ideas, or unpredictable switching from subject to subject?
Altered level of consciousness
Overall, how would you rate this patient’s level of consciousness?
Alert (normal).
Vigilant (hyperalert, overly sensitive to environmental stimuli, startled very easily).
Lethargic (drowsy, easily aroused).
Stupor (difficult to arouse).
Coma (unarousable).
Uncertain.
Disorientation
Was the patient disoriented at any time during the interview, such as thinking that he or she was somewhere other than the hospital, using the wrong bed, or misjudging the time of day?
Memory impairment
Did the patient demonstrate any memory problems during the interview, such as inability to remember events in the hospital or difficulty remembering instructions?
Perceptual disturbances
Did the patient have any evidence of perceptual disturbances, for example, hallucinations, illusions, or misinterpretations (such as thinking something was moving when it was not)?
Psychomotor agitation
Part 1.
At any time during the interview, did the patient have an unusually increased level of motor activity, such as restlessness, picking at bedclothes, tapping fingers, or making frequent sudden changes of position?
Psychomotor retardation
8. Part 2.
At any time during the interview, did the patient have an unusually decreased level of motor activity, such as sluggishness, staring into space, staying in one position for a long time, or moving very slowly?
Alerted sleep-wake cycle
Did the patient have evidence of disturbance of the sleep-wake cycle, such as excessive daytime sleepiness with insomnia at night?
*The questions listed under this topic were repeated for each topic where applicable.

Table A2. The Confusion Assessment Method (CAM) Diagnostic Algorithm* ⁷¹

Table A2. The Confusion Assessment Method (CAM) Diagnostic Algorithm*.

⁷¹

Feature 1. Acute onset or fluctuating course
This feature is usually obtained from a family member or nurse and is shown by positive responses to the following questions: Is there evidence of an acute change in mental status from the patient’s baseline? Did the (abnormal) behavior fluctuate during the day, that is, tend to come and go, or increase and decrease in severity?
Feature 2. Inattention
This feature is shown by a positive response to the following question: Did the patient have difficulty focusing attention, for example, being easily distractible, or having difficulty keeping track of what was being said?
Feature 3. Disorganized thinking
This feature is shown by a positive response to the following question: Was the patient’s thinking disorganized or incoherent, such as rambling or irrelevant conversation, unclear or illogical flow of ideas, or unpredictable switching from subject to subject?
Feature 4. Altered level of consciousness
This feature is shown by any answer other than “alert” to the following question: Overall, how would you rate this patient’s level of consciousness? (alert [normal]), vigilant [hyperalert], lethargic [drowsy and easily aroused], stupor [difficult to arouse], or coma [unarousable])
*The diagnosis of delirium by CAM requires the presence of features 1 and 2 and either 3 or 4

ORCID iDs

Anita M. Albanese https://orcid.org/0000-0002-3028-7722

Natasha Greene https://orcid.org/0000-0003-1505-7459